• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测喉声门癌患者5年死亡率的评分系统。

A scoring system to predict 5-year mortality in patients diagnosed with laryngeal glottic cancer.

作者信息

Jover-Esplá Ana Gabriela, Palazón-Bru Antonio, Folgado-de la Rosa David Manuel, de Juan-Herrero Joaquín, Gil-Guillén Vicente Francisco

机构信息

Otolaryngology Service, General University Hospital of Alicante, Alicante, Spain.

Department of Clinical Medicine, Miguel Hernández University, Alicante, Spain.

出版信息

Eur J Cancer Care (Engl). 2018 Jul;27(4):e12860. doi: 10.1111/ecc.12860. Epub 2018 Jun 5.

DOI:10.1111/ecc.12860
PMID:29870075
Abstract

Only one prognostic model for laryngeal cancer has been published, but it has not been properly validated and is only applicable to patients treated with radiotherapy. Consequently, we constructed, internally validated and implemented in an App (Android), a predictive model of 5-year mortality in patients with glottic cancer in a cohort study of 189 patients with glottic cancer in 2004-2016 in Spain. The main variable was time-to-death. Secondary variables were age, gender, TNM, stage, smoking, alcohol consumption, histology and treatment. A scoring system to predict mortality at 5 years was constructed, validated internally by bootstrapping and then integrated into an Android app. In all, 70 patients died (37.0%, 76 deaths per 1,000 patient-years). The predictive model had the following prognostic factors: larger tumour size, greater degree of lymph node metastasis, higher stage, smoking and alcohol consumption. The internal validation of the model through bootstrapping was satisfactory. In conclusion, a points system to predict mortality at 5 years in patients with glottic cancer has been constructed, internally validated and integrated into an Android application. External validation is suggested to make available a quick and simple tool to establish the prognosis for these patients.

摘要

关于喉癌,仅发表过一种预后模型,但该模型未得到充分验证,且仅适用于接受放射治疗的患者。因此,在一项针对2004年至2016年西班牙189例声门癌患者的队列研究中,我们构建、内部验证并在一款应用程序(安卓系统)中实现了声门癌患者5年死亡率的预测模型。主要变量为死亡时间。次要变量包括年龄、性别、TNM、分期、吸烟、饮酒、组织学类型和治疗情况。构建了一个预测5年死亡率的评分系统,通过自抽样法进行内部验证,然后集成到一个安卓应用程序中。共有70例患者死亡(37.0%,每1000患者年有76例死亡)。该预测模型的预后因素如下:肿瘤尺寸较大、淋巴结转移程度较高、分期较高、吸烟和饮酒。通过自抽样法对模型进行的内部验证结果令人满意。总之,已构建了一个预测声门癌患者5年死亡率的评分系统,进行了内部验证并集成到一个安卓应用程序中。建议进行外部验证,以便提供一个快速简便的工具来确定这些患者的预后。

相似文献

1
A scoring system to predict 5-year mortality in patients diagnosed with laryngeal glottic cancer.一种用于预测喉声门癌患者5年死亡率的评分系统。
Eur J Cancer Care (Engl). 2018 Jul;27(4):e12860. doi: 10.1111/ecc.12860. Epub 2018 Jun 5.
2
A predictive model for recurrence in patients with glottic cancer implemented in a mobile application for Android.用于 Android 移动应用程序的声门型癌症患者复发预测模型。
Oral Oncol. 2018 May;80:82-88. doi: 10.1016/j.oraloncology.2018.03.021. Epub 2018 Apr 4.
3
Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.经口激光显微手术治疗声门癌中病理确定的肿瘤体积的预后意义
Clin Otolaryngol. 2015 Dec;40(6):610-5. doi: 10.1111/coa.12421.
4
A scoring system to predict breast cancer mortality at 5 and 10 years.预测乳腺癌患者 5 年和 10 年死亡率的评分系统。
Sci Rep. 2017 Mar 24;7(1):415. doi: 10.1038/s41598-017-00536-7.
5
A one-year risk score to predict all-cause mortality in hypertensive inpatients.预测高血压住院患者全因死亡率的一年风险评分。
Eur J Intern Med. 2019 Jan;59:77-83. doi: 10.1016/j.ejim.2018.07.010. Epub 2018 Jul 13.
6
[Treatment and prognosis of stage T3 glottic laryngeal cancer--a report of 65 cases].T3期声门型喉癌的治疗与预后——附65例报告
Ai Zheng. 2006 Jan;25(1):85-7.
7
Glottic and supraglottic laryngeal carcinoma: differences in epidemiology, clinical characteristics and prognosis.声门型和声门上型喉癌:流行病学、临床特征及预后的差异
Acta Otolaryngol. 1999;119(7):847-51. doi: 10.1080/00016489950180531.
8
Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.T1期声门癌患者治疗前血红蛋白水平的意义
Radiat Oncol Investig. 1999;7(1):42-8. doi: 10.1002/(SICI)1520-6823(1999)7:1<42::AID-ROI6>3.0.CO;2-W.
9
[Treatment and prognosis of stage IV glottic laryngeal cancer].[IV 期声门型喉癌的治疗与预后]
Ai Zheng. 2008 Jan;27(1):71-4.
10
Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.早期声门癌患者的放射治疗:一组连续入选的未筛选患者的单因素和多因素分析
Cancer. 2003 Aug 15;98(4):765-72. doi: 10.1002/cncr.11575.

引用本文的文献

1
Development and Validation of an Immune-Related Signature for the Prediction of Recurrence Risk of Patients With Laryngeal Cancer.用于预测喉癌患者复发风险的免疫相关特征的开发与验证
Front Oncol. 2021 Dec 16;11:683915. doi: 10.3389/fonc.2021.683915. eCollection 2021.